Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAnagement of METastatic Disease in Campania (MAMETIC): Role of Radiotherapy in an Italian Region: Protocol for an Observational Multicenter Trial

NCT04595032 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT04595032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04595032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAnagement of METastatic Disease in Campania (MAMETIC): Role of Radiotherapy in an Italian Region: Protocol for an Observational Multicenter Trial
Lead sponsor
National Cancer Institute, Naples
Phase
Observational
Overall status
Completed
Start date
September 11, 2020
Completion date
February 8, 2024
Enrollment
3,234 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic disease